Pharmacovigilance collects and analyzes post-approval drug data to ensure long-term safety. It detects, evaluates and prevents adverse effects from drugs or vaccines. Moreover, all medicines and vaccines undergo rigorous safety and efficacy tests in clinical trials before authorization.

Evolving Challenges
As therapeutics grow more complex and personalized, biopharma companies face new challenges in tracking adverse reactions. They must also comply with diverse pharmacovigilance guidelines from global regulators. Additionally, our webinars cover strategies for outsourcing, managing safety reporting in emerging markets and innovative pharmacovigilance models.

Staying Informed
Our webinars keep industry professionals updated on global safety regulation developments. For instance, the COVID-19 vaccines have increased public focus on safety monitoring and reporting systems.

Digital Transformation
The pharmacovigilance industry now embraces digital tools, such as automation and AI, to replace manual processes. Furthermore, companies are unifying safety applications, including reporting, submission gateways and data management. Modern cloud technologies also streamline workflows by providing secure, anytime access to safety data.

Follow our pharmacovigilance webinars to learn from industry experts about digital transformations and new regulatory systems.